Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

8 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Tocilizumab in COVID-19: The Cerrahpaşa-PREDICT score.
Eşkazan AE, Balkan İİ, Demirbaş KC, Ar MC, Karaali R, Sekibağ Y, Mulamahmutoğlu S, Yartaş Dumanlı G, Çakmak F, Özgür Yurttaş N, Kurt F, Aladağ Kurt S, Kuşkucu M, Ürkmez S, Börekçi Ş, Saribal D, Mete B, Bavunoğlu I, Dikmen Y, Aygün G, Midilli K, Tabak F. Eşkazan AE, et al. Among authors: ozgur yurttas n. J Infect Chemother. 2021 Sep;27(9):1329-1335. doi: 10.1016/j.jiac.2021.05.007. Epub 2021 May 12. J Infect Chemother. 2021. PMID: 34120824 Free PMC article.
Dasatinib-induced pulmonary arterial hypertension.
Özgür Yurttaş N, Eşkazan AE. Özgür Yurttaş N, et al. Br J Clin Pharmacol. 2018 May;84(5):835-845. doi: 10.1111/bcp.13508. Epub 2018 Mar 6. Br J Clin Pharmacol. 2018. PMID: 29334406 Free PMC article. Review.
The Outcomes of Chronic Myeloid Leukemia Patients With Molecular Warning Responses During Imatinib Treatment According to the European LeukemiaNet 2013 Recommendations.
Soysal T, Eskazan AE, Serin I, Sadri S, Keskin D, Ozgur Yurttas N, Berk S, Erdogan Ozunal I, Salihoglu A, Ar MC, Ongoren S, Baslar Z, Ozbek U, Aydin Y. Soysal T, et al. Among authors: ozgur yurttas n. Clin Lymphoma Myeloma Leuk. 2019 Jul;19(7):e377-e384. doi: 10.1016/j.clml.2019.03.028. Epub 2019 Apr 4. Clin Lymphoma Myeloma Leuk. 2019. PMID: 31088736
Efficacy and Safety of Imatinib Treatment in Elderly Patients With Chronic Myeloid Leukemia: Real-Life Data and a Single-Center Experience.
Eşkazan AE, Özmen D, Öztaş M, Bektaş F, Bayraktar EA, Sadri S, Keskin D, Özgür Yurttaş N, Elverdi T, Salihoğlu A, Ar MC, Öngören Ş, Başlar Z, Aydın Y, Soysal T. Eşkazan AE, et al. Among authors: ozgur yurttas n. Clin Lymphoma Myeloma Leuk. 2021 Aug;21(8):549-557. doi: 10.1016/j.clml.2021.04.005. Epub 2021 Apr 20. Clin Lymphoma Myeloma Leuk. 2021. PMID: 34052176
Effect of Tyrosine Kinase Inhibitor Therapy on Estimated Glomerular Filtration Rate in Patients with Chronic Myeloid Leukemia.
Sönmez Ö, Özgür Yurttaş N, İhtiyaroğlu İ, Çakır HM, Atlı Z, Elverdi T, Salihoğlu A, Seyahi N, Ar MC, Öngören Ş, Başlar Z, Soysal T, Eşkazan AE. Sönmez Ö, et al. Among authors: ozgur yurttas n. Clin Lymphoma Myeloma Leuk. 2024 Apr;24(4):232-239. doi: 10.1016/j.clml.2023.12.004. Epub 2023 Dec 28. Clin Lymphoma Myeloma Leuk. 2024. PMID: 38281820